Annex A. Science And Technology Objectives (STOs)
Army Science and Technology Master Plan (ASTMP 1997)


III.J.04. Antiparasitic Drug Program. By FY98, transition to advanced development antiparasitic drugs capable of preventing or treating malaria or leishmaniasis. Candidates include arteether (parenteral treatment of severe drug resistant malaria), FY96; topical paromomycin/gentamicin (cutaneous leishmaniasis treatment), FY96; Floxacrine analog (malaria treatment), FY98; atovoquone-proguanil (malaria prophylaxis), FY97; artemisinin analog (malaria prophylaxis), FY01.

Supports: Army Modernization Plan, Medical Annex O—Project, Sustain, and Protect the Force. The Medical Threat Facing a Force Projection Army (1994). Food and Drug Administration regulatory requirements.

STO Manager: TSO: TRADOC POC:
COL W. H. Bancroft MAJ Mark Seymour Herbert Russakoff
MRMC SARD-TM CSS Battle Lab
301-619-7567 703-695-5615 804-734-0599